Brain+ CEO: “CST is becoming the standard in dementia care”

Brain+ is a health tech company focused on treatment and management of dementia.

Centred around Cognitive Stimulation Therapy, the company’s approach has the potential to revolutionize dementia care. CEO Kim Baden-Kristensen stopped by the BioStock Studio to talk about Brain+’s path-to-market and the future of dementia management.